Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Diabetes Care 28, 10921100
Accessed January 22, 2026
Tirzepatide's dual agonism represents a novel approach to metabolic disease
Last reviewed: July 10, 2026 Last updated: July 10, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Targeted monitoring is advisable for men on long-term GLP-1 therapy, particularly those who have lost significant weight or have specific risk factors
US$ 23.29
US$ 23.54
US$ 21.12
US$ 23.29
US$ 20.38
%2Fcase%2Fdetail_images%2Fc9435_detail.jpg&w=1920&q=75)
US$ 28.41
US$ 26.57
US$ 23.01
US$ 25.36
